Acorah Software Products - Accounts Production 19.2.450 false true 30 April 2025 1 May 2024 false true No description of principal activity 1 May 2025 30 April 2026 30 April 2026 14798787 Mr Sukhjeevan Jandu iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14798787 2025-04-30 14798787 2026-04-30 14798787 2025-05-01 2026-04-30 14798787 frs-core:CurrentFinancialInstruments 2026-04-30 14798787 frs-bus:PrivateLimitedCompanyLtd 2025-05-01 2026-04-30 14798787 frs-bus:FilletedAccounts 2025-05-01 2026-04-30 14798787 frs-bus:Micro-entities 2025-05-01 2026-04-30 14798787 frs-bus:AuditExempt-NoAccountantsReport 2025-05-01 2026-04-30 14798787 frs-bus:Director1 2025-05-01 2026-04-30 14798787 2024-04-30 14798787 2025-04-30 14798787 2024-05-01 2025-04-30 14798787 frs-core:CurrentFinancialInstruments 2025-04-30
Registered number: 14798787
Jandu Healthcare limited
Financial Statements
For The Year Ended 30 April 2026
Balance Sheet
Registered number: 14798787
2026 2025
£ £
Fixed assets 1,107 600
Current assets 73,044 80,951
Creditors: Amounts Falling Due Within One Year (14,245 ) (22,544 )
NET CURRENT ASSETS 58,799 58,407
TOTAL ASSETS LESS CURRENT LIABILITIES 59,906 59,007
NET ASSETS 59,906 59,007
CAPITAL AND RESERVES 59,906 59,007

Notes

1. General Information
Jandu Healthcare limited is a private company, limited by shares, incorporated in England & Wales, registered number 14798787 . The registered office is 6, Hasted Close, Greenhithe, Kent, DA9 9HT.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2025: 1)
1 1
For the year ending 30 April 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr Sukhjeevan Jandu
Director
12 May 2026